Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / chromosome aberration study in mammalian cells
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1989
Report date:
1989

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
in vitro mammalian chromosome aberration test

Test material

Constituent 1
Chemical structure
Reference substance name:
N-[[(4-methylphenyl)sulfonyl]methyl]formamide
EC Number:
700-490-2
Cas Number:
36635-56-0
Molecular formula:
C9H11NO3S
IUPAC Name:
N-[[(4-methylphenyl)sulfonyl]methyl]formamide
Details on test material:
- Name of test material (as cited in study report): CGA 224433
- Physical state: solid
- Analytical purity: ca 100%
- Lot/batch No.: P. 709027

Method

Species / strain
Species / strain / cell type:
Chinese hamster Ovary (CHO)
Metabolic activation:
with and without
Test concentrations with justification for top dose:
Toxicity test:
9.77 - 5000.0µg/ml range

Without activation:
125.0 - 1000.0µg/ml range

With microsomal activation:
200.0 - 1600.0µg/ml range
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
Controlsopen allclose all
Untreated negative controls:
yes
Remarks:
DMSO
Positive controls:
yes
Positive control substance:
cyclophosphamide
Remarks:
harvesting time 21hrs only

Migrated to IUCLID6: 40.0µg/ml
Untreated negative controls:
yes
Remarks:
DMSO
Positive controls:
yes
Positive control substance:
mitomycin C
Remarks:
harvesting time 21hrs only

Migrated to IUCLID6: 1.0µg/ml
Details on test system and experimental conditions:
METHOD OF APPLICATION: in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk

DURATION
- Preincubation period: 22hrs
- Exposure duration: 3hrs
- Expression time (cells in growth medium): 4hrs and 21hrs

DETERMINATION OF CYTOTOXICITY
- Method: mitotic suppression
Evaluation criteria:
Criteria for positive response:
- a test substance is considered to be active if, in comparison to the negative control, a marked increase in the number of specific chromosomal aberrations appear or if an increased number of exchange figures appear together with a high number of other specific chromosomal aberrations such as breaks or fragments
- a concentration-related response in the number of aberrations should be demonstrable

Results and discussion

Test results
Species / strain:
Chinese hamster Ovary (CHO)
Metabolic activation:
with and without
Genotoxicity:
positive
Remarks:
with and without activation
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
positive with metabolic activation 21hrs only
positive without metabolic activation both 4hrs and 21hrs

In the experiment with a harvesting time of 4 hours performed without microsomal activation, at concentrations of 1000µg/ml an increase in specific chromosomal aberrations was registered.
In the experiment with a harvesting time of 21 hours performed without microsomal activation, at concentrations of 1000µg/ml a marked increase in specific chromosomal aberrations was detected (23%).
In the experiment with a harvesting time of 21 hours performed with microsomal activation, at concentrations of 1600µg/ml 19% of metaphases with specific chromosomal aberrations was detected, thereof 9% containing exchange figures.

Thus the results indicate that under the given experimental conditions CGA 224433, in 21hrs with and without activation and 4hrs without activation, exerted a mutagenic effect in Chinese hamster ovary cells in vitro.
Executive summary:

CGA 224433 under test conditions was seen to exert a mutagenic effect on the tested cells and thus suggests this substance is a cause of concern for man owing to possible carcinogenic effects and should be assign the appropriate hazard phrases

EU classification R40 limited evidence of carcenogenic effect

GHS classifiaction Category 2 suspected human carcinogen.